Caid 75 mg (Tablet (Enteric Coated))
Medicine Details
| Category | Details |
|---|---|
| Generic | Aspirin |
| Company | Jayson pharmaceuticals ltd |
Indications
- Prophylaxis against arterial occlusive events
- Mild to moderate pain
- Chronic disease accompanied by pain and inflammation
- Antipyretic
Pharmacology
Decreases platelet aggregation, inhibits thrombus formation, has analgesic, anti-inflammatory, and antipyretic properties
Dosage & Administration
- 1-3 tablets 6 hourly with a maximum daily dose of 4 gm for pain and inflammation
- 150 mg-300 mg immediately suspected acute coronary syndrome
- 150 mg daily for 1 month after myocardial infarction
- 150 mg-300 mg daily for acute ischaemic stroke/Transient ischaemic stroke (TIA)
- 75 mg-300 mg daily following bypass surgery
Interaction
Enhances the effect of anticoagulants, oral hypoglycaemic agents, phenytoin, and sodium valproate. Inhibits the uricosuric effect of probenecid. May increase the toxicity of sulphonamides.
Contraindications
- Children less than 12 years (Reye's syndrome)
- Breastfeeding
- Active peptic ulcer
- Bleeding due to haemophilia
- Intracranial haemorrhage
- Other ulceration
Side Effects
Mild side effects including nausea, dyspepsia, gastrointestinal ulceration, and bronchospasm
Pregnancy & Lactation
Avoid use during the last 3 months of pregnancy. Administer with caution to lactating mothers.
Precautions & Warnings
Administer cautiously in asthma, uncontrolled blood pressure, pregnant women, patients with nasal polyps and nasal allergy
Overdose Effects
Dizziness, tinnitus, sweating, nausea, vomiting, confusion, hyperventilation. Can lead to CNS depression, cardiovascular collapse, and respiratory depression. Treatment includes gastric lavage and forced alkaline diuresis.
Therapeutic Class
Anti-platelet drugs
Storage Conditions
Keep in a cool, dry place, protected from light